Evidence supporting the use of: Curcuminoid
For the health condition: Blood Clots (prevention of)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Curcuminoids, the active compounds found in turmeric (Curcuma longa), have been investigated for their potential anticoagulant and antithrombotic properties. Several in vitro and animal studies suggest that curcuminoids may inhibit platelet aggregation and modulate various factors involved in the coagulation cascade, such as thromboxane, fibrinogen, and certain clotting factors. For example, research published in peer-reviewed journals has demonstrated that curcumin can reduce platelet aggregation and delay thrombus formation in animal models. Some small human studies and clinical trials have also observed modest reductions in markers of clot formation, though these results are not entirely consistent.

Despite these findings, the overall quality of evidence is limited. Most clinical data are preliminary, with small sample sizes, short durations, and varying doses and formulations of curcuminoids. There is also a lack of large-scale, well-controlled human trials that conclusively establish the efficacy and safety of curcuminoids for the prevention of blood clots. Accordingly, while there is a scientific rationale and some experimental support for the antithrombotic effects of curcuminoids, the evidence is not robust enough to warrant widespread clinical use for clot prevention. Individuals on anticoagulant therapy should also be cautious, as curcumin may interact with blood-thinning medications. In summary, curcuminoids show promise but are not yet validated as a primary therapy for blood clot prevention.

More about Curcuminoid
More about Blood Clots (prevention of)

Products containing Curcuminoid

We currently have no products on Vitabase that contain this ingredient.